Mercy Mvundura
Biographic Data
| ID | 5538555 |
|---|---|
| NAME | Mercy Mvundura |
| GIVEN NAMES | Mercy |
| FAMILY NAME | Mvundura |
| SIGNATURE | MVUNDURA M |
| AFFILIATIONS | Program for Appropriate Technology in Health |
| ORCID | 0000-0002-7711-9558 |
| VERIFIED | Yes |
| TOTAL WORKS | 10 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 10 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2009 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Priority implementation research for measles-rubella microarray patches identified using the Child Health and Nutrition Research Initiative methodology
Background: Measles and rubella continue to be a significant global health challenge, disproportionately impacting marginalised communities in low- and middle-income countries (LMICs). Innovative technologies such as measles-rubella microarray patches (MR-MAPs) are currently in development and can potentially improve immunisation coverage and equity through their unique product characteristics. Nonetheless, the limited evidence around their use c…
Cost-effectiveness of wastewater-based environmental surveillance for Sars-CoV-2 in Blantyre, Malawi and Kathmandu, Nepal
Wastewater-based environmental surveillance (ES) has been demonstrated to provide an early warning signal to predict variant-driven waves of pathogens such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Our study evaluated the potential cost-effectiveness of ES for SARS-CoV-2 compared with clinical testing alone. We used the Covasim agent-based model of COVID-19 to simulate disease transmission for hypothetical populations in Bl…
Evaluating the cost and operational context for national human papillomavirus (HPV) vaccine delivery in three regions of Ethiopia
Cervical cancer is the second leading cause of cancer deaths among women in Ethiopia. Human papillomavirus (HPV) vaccination is a primary prevention method for cervical cancer and was introduced in Ethiopia in 2018. We conducted a cross-sectional, mixed-methods study to understand the operational context for the HPV vaccination program and the associated costs in three regions of Ethiopia. Operations research provided insights on the frequency an…
Rotavirus vaccine product switch in Ghana
Ghana introduced rotavirus vaccine (ROTARIX 1-dose presentation) into the routine national immunization program in 2012 and switched to a different product (ROTAVAC 5-dose presentation) in 2020. ROTAVAC has a lower price per dose (US$0.85 versus US$2.15 for ROTARIX) and smaller cold chain footprint but requires more doses per regimen (three versus two). This study estimates the supply chain and service delivery costs associated with each product,…
Accelerating the Development of Measles and Rubella Microarray Patches to Eliminate Measles and Rubella
Measles and rubella microarray patches (MR-MAPs) are critical in achieving measles and rubella eradication, a goal highly unlikely to meet with current vaccines presentations. With low commercial incentive to MAP developers, limited and uncertain funding, the need for investment in a novel manufacturing facility, and remaining questions about the source of antigen, product demand, and regulatory pathway, MR-MAPs are unlikely to be prequalified by…
Evaluating the potential cost-effectiveness of microarray patches to expand access to hepatitis B birth dose vaccination in low-and middle-income countries
Timely birth dose vaccination is key for achieving elimination of hepatitis B, however, programmatic requirements for delivering current vaccine presentations to births outside of health facilities inhibits coverage within many low-and middle-income countries (LMICs). Vaccine technologies in development such as microarray patches (MAPs) could assist in overcoming these barriers, but procurement could incur higher per-dose commodity costs than cur…
Cost of wastewater-based environmental surveillance for Sars-CoV-2
Environmental surveillance of rivers and wastewater for SARS-CoV-2 detection has been explored as an innovative way to surveil the pandemic. This study estimated the economic costs of conducting wastewater-based environmental surveillance for SARS-CoV-2 to inform decision making if countries consider continuing these efforts. We estimated the cost of two SARS-CoV-2 environmental surveillance pilot studies conducted in Blantyre, Malawi, and Kathma…
Cost-effectiveness of an HPV self-collection campaign in Uganda
With the availability of a low-cost HPV DNA test that can be administered by either a healthcare provider or a woman herself, programme planners require information on the costs and cost-effectiveness of implementing cervical cancer screening programmes in low-resource settings under different models of healthcare delivery. Using data from the START-UP demonstration project and a micro-costing approach, we estimated the health and economic impact…
Cost-effectiveness of an HPV self-collection campaign in Uganda
Economic Productivity by Age and Sex
BACKGROUND: Human capital estimates of labor productivity are often used to estimate the economic impact of diseases and injuries that cause incapacitation or death. OBJECTIVES: Estimates of average hourly, annual, and lifetime economic productivity, both market and household, were calculated in 2007 US dollars for 5-year age groups for men, women, and both sexes in the United States. RESEARCH DESIGN: Data from the American Time Use Survey were u…
No prominent works on this page.
Economic Productivity by Age and Sex
BACKGROUND: Human capital estimates of labor productivity are often used to estimate the economic impact of diseases and injuries that cause incapacitation or death. OBJECTIVES: Estimates of average hourly, annual, and lifetime economic productivity, both market and household, were calculated in 2007 US dollars for 5-year age groups for men, women, and both sexes in the United States. RESEARCH DESIGN: Data from the American Time Use Survey were u…
Cost-effectiveness of an HPV self-collection campaign in Uganda
With the availability of a low-cost HPV DNA test that can be administered by either a healthcare provider or a woman herself, programme planners require information on the costs and cost-effectiveness of implementing cervical cancer screening programmes in low-resource settings under different models of healthcare delivery. Using data from the START-UP demonstration project and a micro-costing approach, we estimated the health and economic impact…
Cost-effectiveness of an HPV self-collection campaign in Uganda
Accelerating the Development of Measles and Rubella Microarray Patches to Eliminate Measles and Rubella
Measles and rubella microarray patches (MR-MAPs) are critical in achieving measles and rubella eradication, a goal highly unlikely to meet with current vaccines presentations. With low commercial incentive to MAP developers, limited and uncertain funding, the need for investment in a novel manufacturing facility, and remaining questions about the source of antigen, product demand, and regulatory pathway, MR-MAPs are unlikely to be prequalified by…
Evaluating the potential cost-effectiveness of microarray patches to expand access to hepatitis B birth dose vaccination in low-and middle-income countries
Timely birth dose vaccination is key for achieving elimination of hepatitis B, however, programmatic requirements for delivering current vaccine presentations to births outside of health facilities inhibits coverage within many low-and middle-income countries (LMICs). Vaccine technologies in development such as microarray patches (MAPs) could assist in overcoming these barriers, but procurement could incur higher per-dose commodity costs than cur…
Cost of wastewater-based environmental surveillance for Sars-CoV-2
Environmental surveillance of rivers and wastewater for SARS-CoV-2 detection has been explored as an innovative way to surveil the pandemic. This study estimated the economic costs of conducting wastewater-based environmental surveillance for SARS-CoV-2 to inform decision making if countries consider continuing these efforts. We estimated the cost of two SARS-CoV-2 environmental surveillance pilot studies conducted in Blantyre, Malawi, and Kathma…
Rotavirus vaccine product switch in Ghana
Ghana introduced rotavirus vaccine (ROTARIX 1-dose presentation) into the routine national immunization program in 2012 and switched to a different product (ROTAVAC 5-dose presentation) in 2020. ROTAVAC has a lower price per dose (US$0.85 versus US$2.15 for ROTARIX) and smaller cold chain footprint but requires more doses per regimen (three versus two). This study estimates the supply chain and service delivery costs associated with each product,…
Evaluating the cost and operational context for national human papillomavirus (HPV) vaccine delivery in three regions of Ethiopia
Cervical cancer is the second leading cause of cancer deaths among women in Ethiopia. Human papillomavirus (HPV) vaccination is a primary prevention method for cervical cancer and was introduced in Ethiopia in 2018. We conducted a cross-sectional, mixed-methods study to understand the operational context for the HPV vaccination program and the associated costs in three regions of Ethiopia. Operations research provided insights on the frequency an…
Cost-effectiveness of wastewater-based environmental surveillance for Sars-CoV-2 in Blantyre, Malawi and Kathmandu, Nepal
Wastewater-based environmental surveillance (ES) has been demonstrated to provide an early warning signal to predict variant-driven waves of pathogens such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Our study evaluated the potential cost-effectiveness of ES for SARS-CoV-2 compared with clinical testing alone. We used the Covasim agent-based model of COVID-19 to simulate disease transmission for hypothetical populations in Bl…
Priority implementation research for measles-rubella microarray patches identified using the Child Health and Nutrition Research Initiative methodology
Background: Measles and rubella continue to be a significant global health challenge, disproportionately impacting marginalised communities in low- and middle-income countries (LMICs). Innovative technologies such as measles-rubella microarray patches (MR-MAPs) are currently in development and can potentially improve immunisation coverage and equity through their unique product characteristics. Nonetheless, the limited evidence around their use c…
Business (6 works) · Medicine (6 works) · Economics (5 works) · Environmental health (5 works) · Cost effectiveness (4 works) · Economic growth (4 works) · Cancer (3 works) · Cervical cancer (3 works) · Cervical Cancer and HPV Research (3 works) · Demography (3 works)